PCI Biotech Holding ASA (PCIB) — Financial Flexibility Index
PCI Biotech Holding ASA (PCIB) has a Financial Flexibility Index of -0.99x as of June 2025. Free cash flow of Nkr-5.95 Million (operating CF Nkr-6.26 Million minus capex Nkr315.50K) represents -1% of total liabilities (Nkr6.01 Million). Check asset allocation strategy of PCI Biotech Holding ASA to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PCI Biotech Holding ASA Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for PCI Biotech Holding ASA across 17 annual periods. See PCIB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for PCI Biotech Holding ASA (2008–2024)
Year-by-year free cash flow to debt coverage for PCI Biotech Holding ASA. For the full company profile including market capitalisation, see PCI Biotech Holding ASA (PCIB) total market value.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.77x | Nkr-13.76 Million | Nkr-13.76 Million | Nkr7.76 Million | ▲ +40.7% |
| 2023 | -2.99x | Nkr-14.97 Million | Nkr-14.97 Million | Nkr5.01 Million | ▲ +69.2% |
| 2022 | -9.71x | Nkr-59.04 Million | Nkr-59.04 Million | Nkr6.08 Million | ▼ -217.0% |
| 2021 | -3.06x | Nkr-67.97 Million | Nkr-68.31 Million | Nkr22.19 Million | ▲ +17.1% |
| 2020 | -3.70x | Nkr-73.47 Million | Nkr-77.39 Million | Nkr19.88 Million | ▼ -28.8% |
| 2019 | -2.87x | Nkr-78.07 Million | Nkr-83.47 Million | Nkr27.20 Million | ▼ -91.2% |
| 2018 | -1.50x | Nkr-25.67 Million | Nkr-31.08 Million | Nkr17.10 Million | ▲ +1.2% |
| 2017 | -1.52x | Nkr-25.21 Million | Nkr-30.62 Million | Nkr16.59 Million | ▲ +56.6% |
| 2016 | -3.50x | Nkr-32.62 Million | Nkr-35.69 Million | Nkr9.31 Million | ▼ -29.2% |
| 2015 | -2.71x | Nkr-32.84 Million | Nkr-32.84 Million | Nkr12.12 Million | ▲ +3.6% |
| 2014 | -2.81x | Nkr-31.67 Million | Nkr-31.67 Million | Nkr11.27 Million | ▲ +8.2% |
| 2013 | -3.06x | Nkr-28.59 Million | Nkr-28.59 Million | Nkr9.34 Million | ▼ -6.8% |
| 2012 | -2.87x | Nkr-24.35 Million | Nkr-24.35 Million | Nkr8.49 Million | ▼ -14.9% |
| 2011 | -2.50x | Nkr-19.05 Million | Nkr-19.05 Million | Nkr7.63 Million | ▼ -114.9% |
| 2010 | -1.16x | Nkr-10.59 Million | Nkr-10.59 Million | Nkr9.12 Million | ▲ +55.2% |
| 2009 | -2.59x | Nkr-16.72 Million | Nkr-16.84 Million | Nkr6.45 Million | ▼ -47.2% |
| 2008 | -1.76x | Nkr-9.29 Million | Nkr-9.41 Million | Nkr5.28 Million | — |